课题基金 / 基金详情

Characterisation of novel regulators of the haemopoeitic system.

Characterisation of novel regulators of the haemopoeitic system.
造血系统新型调节剂的表征。
批准号:
nhmrc : 110298
负责人:
Prof Peter Klinken
金额:
$25.45万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Peter Klinken的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All of the circulating blood cells (including red cells and white cells) develop from a single cell type, called the haemopoietic stem cell (HSC), found in the adult bone marrow. Normally, HSCs are gradually restricted to become only one cell type and once they have started down that pathway can no longer generate cells of another pathway (e.g. once HSC begin to develop into red blood cells, they cannot normally change their direction to become white cells). There are a few examples of mature cells, however, that have changed pathways. We have use one of these, the mouse J2E red cell changing into macrophages, to identify the genes involved in this process. Two of the genes we found, HLS5 and HLS7, are potentially important in lineage determination and normal blood development as well as the formation of blood cancers. This project aims to investigate the roles these genes play in blood development. Much of our work to date has focused on HLS7. The human equivalent of HLS7 was found by an American group independently of us as a gene which causes one type of blood cancer. We have shown HLS7 has dramatic effects on normal blood development and, together, these results clearly show the importance of this gene. Through our studies on how HLS7 works, we have identified another gene, M44, which may be important in regulation of HLS7 and also plan to investigate is function. Finally, HLS5 has similarities to a group of molecules called transcription factors which are known to be key regulators blood development. Clearly, analysis of this gene will further our knowledge in this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF THE NOVEL LEUKEMIA-INDUCING GENE MLF1
  • 批准号:
    nhmrc : 254668
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $26.26万
  • 财政年份:
    2003
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Characterization of HLS5, a novel tumor suppressor gene
  • 批准号:
    nhmrc : 212070
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $27.14万
  • 财政年份:
    2002
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Novel regulators of erythropoiesis identified by yeast two hybrid screening
  • 批准号:
    nhmrc : 980610
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $12.24万
  • 财政年份:
    1998
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Genes that control blood cell production
  • 批准号:
    nhmrc : 970095
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $11.64万
  • 财政年份:
    1997
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: